|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.68 USD | -5.62% |
|
-0.58% | +55.54% |
| Market Cap | 4.08B 3.56B 3.29B 3.04B 5.76B 389B 5.86B 39.29B 15.43B 191B 15.3B 14.97B 658B | P/E 2026 * |
-10.6x | P/E 2027 * | -10.7x |
|---|---|---|---|---|---|
| Enterprise Value | 3.4B 2.98B 2.74B 2.53B 4.81B 324B 4.89B 32.79B 12.88B 160B 12.77B 12.49B 549B | EV / Sales 2026 * |
83x | EV / Sales 2027 * | 30.1x |
| Free-Float |
90.08% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Denali Therapeutics Inc.
| 1 day | -5.62% | ||
| 1 week | -0.58% | ||
| Current month | -0.16% | ||
| 1 month | +24.60% | ||
| 3 months | +33.54% | ||
| 6 months | +50.35% | ||
| Current year | +55.54% |
| 1 week | 25.05 |  | 27.3 |
| 1 month | 20.92 | | 27.3 |
| Current year | 15.34 | | 27.3 |
| 1 year | 12.58 | | 27.3 |
| 3 years | 10.57 | | 33.33 |
| 5 years | 10.57 | | 73.42 |
| 10 years | 10.57 | | 93.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Schuth
DFI | Director of Finance/CFO | 52 | 2022-04-30 |
Ryan Watts
CEO | Chief Executive Officer | 50 | 2015-07-31 |
Peter Chin
CTO | Chief Tech/Sci/R&D Officer | 58 | 2025-11-05 |
| Director | Title | Age | Since |
|---|---|---|---|
Ryan Watts
BRD | Director/Board Member | 50 | 2015-02-28 |
Jay Flatley
BRD | Director/Board Member | 73 | 2015-03-31 |
David Schenkein
BRD | Director/Board Member | 68 | 2015-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-02 | Free | Director | 25,634 | 0.0162% | ||
| 06-02 | Free | Director | 25,634 | 0.0162% | ||
| 06-02 | Free | Director | 25,634 | 0.0162% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.62% | -0.58% | +67.30% | -11.96% | 4.08B | |
| -4.14% | -8.06% | +57.35% | +117.24% | 54.63B | |
| +1.84% | -0.66% | +75.79% | +93.87% | 54.88B | |
| -2.24% | +3.59% | +19.60% | +466.72% | 25.06B | |
| -1.60% | -6.21% | -19.69% | -14.84% | 23.14B | |
| +2.43% | +1.06% | +47.70% | -0.11% | 19.88B | |
| -3.19% | 0.00% | +33.99% | -26.87% | 17.55B | |
| -6.84% | +2.18% | +195.12% | +357.18% | 16.5B | |
| -1.05% | +1.16% | +25.08% | +196.28% | 14.2B | |
| +8.74% | +3.51% | +53.81% | - | 15.36B | |
| Average | -1.17% | -0.31% | +55.61% | +130.83% | 24.53B | |
| Weighted average by Cap. | -0.99% | -1.44% | +55.25% | +135.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 41M 35.86M 33.08M 30.55M 57.97M 3.91B 58.95M 395M 155M 1.93B 154M 151M 6.62B | 113M 98.99M 91.31M 84.33M 160M 10.79B 163M 1.09B 428M 5.32B 425M 416M 18.28B |
| Net income | -481M -421M -388M -359M -680M -45.89B -692M -4.64B -1.82B -22.61B -1.81B -1.77B -77.72B | -463M -405M -374M -345M -655M -44.2B -666M -4.47B -1.75B -21.77B -1.74B -1.7B -74.86B |
| Net Debt | -674M -590M -544M -503M -954M -64.32B -970M -6.5B -2.55B -31.69B -2.53B -2.48B -109B | -665M -581M -536M -495M -940M -63.4B -956M -6.41B -2.52B -31.23B -2.5B -2.44B -107B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | US$25.68 | -5.62% | 1,397,862 |
| 26-07-09 | US$27.21 | +1.95% | 1,567,389 |
| 26-07-08 | US$26.69 | +1.44% | 1,300,642 |
| 26-07-07 | US$26.31 | +2.21% | 1,437,184 |
| 26-07-06 | US$25.74 | -0.35% | 1,335,401 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DNLI Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
